<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" lang="en">
<head>
<meta http-equiv="default-style" content="application/xhtml+xml; charset=utf-8" />
<title>Clinical Anesthesia Fundamentals, 2e</title>
<link rel="stylesheet" type="text/css" href="css/style.css"/>
</head>
<body epub:type="bodymatter">
<section epub:type="chapter">
<div id="main_container">
<header>
<a id="page964"></a>
<h1 id="app03" class="chapter_name"><span class="chapter_name">C</span></h1>
<h2 class="chapter_title">Pacemaker and Implantable Cardiac Defibrillator Protocols</h2>
</header>
<p class="UL1">Cardiac implantable electronic devices (CIEDs)&#x2014;pacemakers</p>
<p class="UL1">Cardiac implantable electronic devices (CIEDs)&#x2014;implantable cardiac defibrillators (ICDs)</p>
<p class="UL1">Potential intraoperative problems with cardiac electronic implantable devices</p>
<p class="UL1">General principles of perioperative management of patients with CIED</p>
<p class="UL1">Risk mitigation strategies</p>
<p class="UL1">Recommendations for postoperative follow-up of the patient with CIED</p>
<p class="UL1">Optimization of pacing after cardiopulmonary bypass (CPB)</p>
<a id="page965"></a>
<p class="h7a">Cardiac Implantable Electronic Devices&#x2014;Pacemakers</p>
<p class="nonindent">Pacemakers are devices that deliver electrical energy and control the patient&#x2019;s conduction system when necessary (<strong><a href="#ttC-1">Table C.1</a></strong>).</p>
<p class="indent">Common indications for permanent pacemaker implantation: (For a complete list of indications, please refer to the ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.)</p>
<ol class="u_num2">
<li><span>Sinus node dysfunction:</span>
<ul class="u_bullb1">
<li><span>Documented symptomatic bradycardia</span></li>
<li><span>Documented symptomatic chronotropic incompetence</span></li>
<li><span>Documented symptomatic bradycardia induced by essential medical therapy</span></li>
<li><span>Syncope of unexplained origin with inducible sinus bradycardia or pauses on electrophysiologic studies</span></li>
<li><span>Symptomatic patients with assumed sinus bradycardia and no other possible etiologies</span></li></ul></li>
<li><span>Atrioventricular (AV) node dysfunction:</span>
<ul class="u_bullb1">
<li><span>Third-degree AV block</span></li>
<li><span>Type II second-degree AV block</span></li>
<li><span>Symptomatic type I second-degree AV block</span></li>
<li><span>Symptomatic first-degree AV block</span></li>
<li><span>Asymptomatic first-degree AV block with coexisting disease that can impair the conduction system (ie, sarcoidosis, amyloidosis, neuromuscular diseases)</span></li>
<li><span>Drug- or medication-induced AV block that is thought to recur despite discontinuation of the drug or medication</span></li></ul></li>
<li><span>Bifascicular block and:</span>
<ul class="u_bullb1">
<li><span>Alternating bundle-branch block</span></li>
<li><span>Electrophysiologic evidence of a markedly prolonged HV interval &#x2265;100 ms. (His bundle [H] potential and the onset of ventricular activity, also known as the HV interval, is normally 35-45 ms)</span></li>
<li><span>Concomitant neuromuscular disease (ie, myotonic muscular dystrophy, Erb dystrophy)</span></li></ul></li>
<li><span>ST-segment elevation myocardial infarction (STEMI) with second- or third-degree AV block</span></li>
<li><span>Hypersensitive carotid sinus syndrome and neurocardiogenic syncope</span></li>
<li><span>Cardiac transplantation patients who develop persistent inappropriate bradycardia</span></li>
<li><span>Prevention and termination of certain arrhythmias such as the following:</span>
<ul class="u_bullb1">
<li><span>Sustained pause-dependant VT</span></li>
<li><span>High-risk patients with congenital long-QT syndrome</span></li>
<li><span>Recurrent refractory symptomatic atrial fibrillation and SND</span></li>
<li><span>Symptomatic recurrent SVT that is reliably terminated by pacing and catheter ablation and medication management has failed</span></li></ul></li>
<li><span>Hemodynamic indications:</span>
<ul class="u_bullb1">
<li><span>Cardiac resynchronization therapy (CRT) in patients with NYHA class III or ambulatory class IV heart failure with optimal medical management and an ejection fraction (EF) &#x2264;35% and QRS &#x2265;120 ms</span></li>
<li><span>Hypertrophic cardiomyopathy with sinus node dysfunction (SND) or AV node dysfunction</span></li></ul></li>
<li><span>Congenital heart diseases with associated bradyarrhythmias or AV block</span></li></ol>
<a id="page966"></a>
<div class="table">
<p class="TABLEpNUM" id="ttC-1"><strong><span class="tab">Table&#160;C.1</span> Abbreviation Table</strong></p>
<table class="table">
<colgroup>
<col style="width:20%;"></col>
<col style="width:80%;"></col>
</colgroup>
<tr>
<td class="theadleft"><strong>Abbrev.</strong></td>
<td class="theadleft"><strong>Meaning</strong></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>3D</strong></p></td>
<td class="td2"><p class="tbodyleft">Three dimensional</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>ASA</strong></p></td>
<td class="td3"><p class="tbodyleft">American Society of Anesthesiologists</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>ATP</strong></p></td>
<td class="td2"><p class="tbodyleft">Antitachycardia pacing</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>AV</strong></p></td>
<td class="td3"><p class="tbodyleft">Atrioventricular</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>AVB</strong></p></td>
<td class="td2"><p class="tbodyleft">Atrioventricular block</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>BPEG</strong></p></td>
<td class="td3"><p class="tbodyleft">British Pacing and Electrophysiology Group</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>bpm</strong></p></td>
<td class="td2"><p class="tbodyleft">Beats per minute</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>CAD</strong></p></td>
<td class="td3"><p class="tbodyleft">Coronary artery disease</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>CIED</strong></p></td>
<td class="td2"><p class="tbodyleft">Cardiac implantable electronic devices</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>CPB</strong></p></td>
<td class="td3"><p class="tbodyleft">Cardiopulmonary bypass</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>CRP</strong></p></td>
<td class="td2"><p class="tbodyleft">Current return pad</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>CRT</strong></p></td>
<td class="td3"><p class="tbodyleft">Cardiac resynchronization therapy</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>CRT-D</strong></p></td>
<td class="td2"><p class="tbodyleft">Cardiac resynchronization therapy-defibrillation</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>CT</strong></p></td>
<td class="td3"><p class="tbodyleft">Cautery tool</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>DCM</strong></p></td>
<td class="td2"><p class="tbodyleft">Dilated cardiomyopathy</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>ECG</strong></p></td>
<td class="td3"><p class="tbodyleft">Electrocardiogram</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>ECT</strong></p></td>
<td class="td2"><p class="tbodyleft">Electroconvulsive therapy</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>EF</strong></p></td>
<td class="td3"><p class="tbodyleft">Ejection fraction</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>EMI</strong></p></td>
<td class="td2"><p class="tbodyleft">Electromagnetic interference</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>HCM</strong></p></td>
<td class="td3"><p class="tbodyleft">Hypertrophic cardiomyopathy</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>HR</strong></p></td>
<td class="td2"><p class="tbodyleft">Heart rate</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>HRS</strong></p></td>
<td class="td3"><p class="tbodyleft">Heart Rhythm Society</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>HV</strong></p></td>
<td class="td2"><p class="tbodyleft">HV interval</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>ICD</strong></p></td>
<td class="td3"><p class="tbodyleft">Implantable cardiac defibrillators</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>LV</strong></p></td>
<td class="td2"><p class="tbodyleft">Left ventricle</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>LVOT</strong></p></td>
<td class="td3"><p class="tbodyleft">Left ventricular outflow tract</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>MRI</strong></p></td>
<td class="td2"><p class="tbodyleft">Magnetic resonance imaging</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>NASPE</strong></p></td>
<td class="td3"><p class="tbodyleft">North American Society of Pacing and Electrophysiology</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>NBG</strong></p></td>
<td class="td2"><p class="tbodyleft">N (NASPE), B (BPEG), G (GENERIC)</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>PG</strong></p></td>
<td class="td3"><p class="tbodyleft">Pulse generator</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>PP</strong></p></td>
<td class="td2"><p class="tbodyleft">External cardioversion-defibrillation pads or paddles</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>RA</strong></p></td>
<td class="td3"><p class="tbodyleft">Right atrium</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>RF</strong></p></td>
<td class="td2"><p class="tbodyleft">Radio frequency</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>R&#x0026;R</strong></p></td>
<td class="td3"><p class="tbodyleft">Rate and rhythm</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>RT</strong></p></td>
<td class="td2"><p class="tbodyleft">Radiation therapy</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>RV</strong></p></td>
<td class="td3"><p class="tbodyleft">Right ventricle</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>SCD</strong></p></td>
<td class="td2"><p class="tbodyleft">Sudden cardiac death</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>SND</strong></p></td>
<td class="td3"><p class="tbodyleft">Sinus node dysfunction</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>STEMI</strong></p></td>
<td class="td2"><p class="tbodyleft">ST-segment elevation myocardial infarction</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>TUNA</strong></p></td>
<td class="td3"><p class="tbodyleft">Transurethral needle ablation</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>TURP</strong></p></td>
<td class="td2"><p class="tbodyleft">Transurethral resection of prostate</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>VT</strong></p></td>
<td class="td3"><p class="tbodyleft">Ventricular tachycardia</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>VF</strong></p></td>
<td class="td2"><p class="tbodyleft">Ventricular fibrillation</p></td>
</tr>
</table>
</div>
<a id="page967"></a>
<p class="h7a">Cardiac Implantable Electronic Devices (CIEDs)&#x2014;Implantable Cardiac Defibrillators (ICDs)</p>
<p class="nonindent">Implantable cardiac defibrillators (ICDs) are rhythm management devices that consist of a generator and a lead system. One lead is usually placed in the right atrium and the second lead in the right ventricular apex. A specific type of ICD is the biventricular pacemaker used for cardiac resynchronization therapy (CRT). This device will have a third lead placed in the coronary sinus to pace the left ventricular (LV) lateral wall in synchrony with the right ventricle (RV), in the patient with EF &#x2264;35% and a QRS duration &#x2265;120 ms.</p>
<p class="indent">Common indications for ICD implantation: (For a complete list of indications, please refer to the ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.)</p>
<ol class="u_num2">
<li><span>Prevention of sudden cardiac death (SCD) in survivors of prior cardiac arrest due to VF or unstable VT without a reversible cause.</span></li>
<li><span>Structural heart disease with spontaneous sustained VT or syncope not otherwise specified.</span></li>
<li><span>Sustained VT with normal or near-normal LV function.</span></li>
<li><span>Syncope of undetermined origin with clinically relevant, hemodynamically significant, sustained VT or VF induced by an electrophysiologic study.</span></li>
<li><span>Unexplained syncope with significant LV dysfunction and nonischemic DCM.</span></li>
<li><span>Prior myocardial infarction (not within 40 days) and an EF &#x2264;35%.</span></li>
<li><span>Nonischemic dilated cardiomyopathy (DCM) and an EF &#x2264;35%.</span></li>
<li><span>Nonsustained VT due to prior MI with an EF &#x2264;&#x2212;40% and inducible VF or sustained VT on electrophysiologic study.</span></li>
<li><span>HCM with one or more risk factors for SCD.</span></li></ol>
<div class="table">
<p class="TABLEpNUM" id="ttC-2"><strong><span class="tab">Table&#160;C.2</span> Generic Pacemaker Code: NASPE/BPEG Revised (2002)</strong></p>
<p class="timage"><img src="images/ttc-2.jpg" alt="img"/></p>
</div>
<a id="page968"></a>
<ol class="u_num2" start="11">
<li><span>Arrhythmogenic right ventricular dysplasia/cardiomyopathy with one or more risk factors for SCD. (<strong><a href="#ttC-2">Table C.2</a></strong>)</span></li>
<li><span>Long-QT syndrome with syncope and/or VT due to beta-blocker therapy or other risk factors for SCD.</span></li>
<li><span>Brugada syndrome with syncope or VT.</span></li>
<li><span>Catecholaminergic polymorphic VT with syncope while receiving betablocker therapy.</span></li>
<li><span>Diseases associated with cardiac involvement (ie, Chagas disease, giant cell myocarditis, sarcoidosis).</span></li>
<li><span>Familial cardiomyopathy associated with SCD.</span></li>
<li><span>LV noncompaction.</span></li>
</ol>
<p class="h7a">Potential Intraoperative Problems With Cardiac Electronic Implantable Devices</p>
<p class="nonindent">Electromagnetic interference (EMI) with a CIED is more likely when electrocautery is used above the umbilicus in a patient with the CIED implanted in the subclavicular region. Current expert opinion further states that the region 15 cm around the generator and cardiac leads are with the highest risk of EMI interference. For generators placed elsewhere (eg, abdominal site), this 15-cm rule still applies.</p>
<p class="indent"><strong>EMI interference leads to the following:</strong></p>
<ol class="u_num2">
<li><span>Inhibition of pacemaker by EMI</span></li>
<li><span>Inappropriate delivery of antitachycardia therapy by ICD</span></li>
<li><span>Changes in lead parameters:</span>
<ol class="u_lalpha1">
<li><span>Atrial mode switching</span></li>
<li><span>Inappropriate ventricular sensing</span></li>
<li><span>Electrical reset</span></li>
<li><span>Increase in ventricular thresholds</span></li></ol></li>
<li><span>&#x201C;Runaway&#x201D; pacemaker</span></li>
<li><span>Conversion from VOO back to backup mode (reprogramming)</span></li>
<li><span>Transient or permanent loss of capture (<strong><a href="#ttC-3">Table C.3</a></strong>)</span></li></ol>
<div class="table">
<p class="TABLEpNUM" id="ttC-3"><strong><span class="tab">Table&#160;C.3</span> Generic Defibrillator Code (NBG): NASPE/BPEG</strong></p>
<table class="table">
<colgroup>
<col style="width:25%;"></col>
<col style="width:25%;"></col>
<col style="width:25%;"></col>
<col style="width:25%;"></col>
</colgroup>
<tr>
<td class="theadleft"><strong>Position I, Shock Chamber(s)</strong></td>
<td class="theadleft"><strong>Position II, Antitachycardia Pacing Chamber(s)</strong></td>
<td class="theadleft"><strong>Position III, Tachycardia Detection</strong></td>
<td class="theadleft"><strong>Position IV,</strong><sup>a</sup> <strong>Antibradycardia Pacing Chamber(s)</strong></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>O = none</strong></p></td>
<td class="td2"><p class="tbodyleft">O = none</p></td>
<td class="td2"><p class="tbodyleft">E = electrogram</p></td>
<td class="td2"><p class="tbodyleft">O = none</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>A = atrium</strong></p></td>
<td class="td3"><p class="tbodyleft">A = atrium</p></td>
<td class="td3"><p class="tbodyleft">H = hemodynamic</p></td>
<td class="td3"><p class="tbodyleft">A = atrium</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>V = ventricle</strong></p></td>
<td class="td2"><p class="tbodyleft">V = ventricle</p></td>
<td class="td2">&#x00A0;</td>
<td class="td2"><p class="tbodyleft">V = ventricle</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>D = dual (A + V)</strong></p></td>
<td class="td3"><p class="tbodyleft">D = dual (A + V)</p></td>
<td class="td3">&#x00A0;</td>
<td class="td3"><p class="tbodyleft">D = dual (A + V)</p></td>
</tr>
</table>
<p class="tfoot">NBG: N refers to North American Society of Pacing and Electrophysiology (NASPE), now called the Heart Rhythm Society (HRS); B refers to British Pacing and Electrophysiology Group (BPEG); and G refers to generic.</p>
<p class="u_tfoot"><sup>a</sup>For robust identification, position IV is expanded into its complete NBG code. For example, a biventricular-pacing defibrillator with ventricular shock and antitachycardia pacing functionality would be identified as VVE-DDDRV, assuming that the pacing section was programmed DDDRV. Currently, no hemodynamic sensors have been approved for tachycardia detection (position III).</p>
<p class="u_tfoot">Reproduced with permission from: Practice advisory for perioperative management of patients with cardiac rhythm management devices: Pacemakers and implantable cardioverter-defibrillators. A report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. <em>Anesthesiology</em>. 2011;114:247-261. Table 2.</p>
</div>
<a id="page969"></a>
<ol class="u_num2" start="7">
<li><span>Noise reversal mode</span></li>
<li><span>Pacemaker failure after direct contact with electrocautery and cardioversion</span></li>
<li><span>Myocardial burns with increased pacing thresholds if electrocautery travels through leads into the myocardium</span></li>
<li><span>Rate-adaptive pacing (interaction of minute ventilation sensor with ECG/plethysmography)</span></li>
<li><span>Oversensing and inhibition with use of lithotripsy</span></li>
<li><span>Radiofrequency ablation has a high risk of interference due to long episodes of exposure to current</span></li>
<li><span>Therapeutic ionizing radiation is especially damaging to CIEDs by damaging internal components</span></li>
</ol>
<p class="h7a">General Principles of Perioperative Management of Patients With CIED</p>
<ul class="u_bullb"><li><span>The perioperative management of the patient with a CIED is via an individualized recommendation made by the CIED team (electrophysiologist cardiologist) in collaboration with members of the surgical/anesthesia team (perioperative team). The recommendations should not be made by the industry representative without supervision by a physician who is qualified to manage these devices.</span></li>
<li><span>The perioperative team should provide information to the CIED team regarding the upcoming procedure (see <strong><a href="#ttC-4">Table C.4</a></strong>).</span></li>
<li><span>The CIED team should in turn provide information about the device and a recommendation for perioperative management of the device (see <strong><a href="#ttC-5">Table C.5</a></strong>).</span></li>
<li><span>The patient with a pacemaker should have had an interrogation of the device in the 12 months prior to the surgical procedure, whereas the patient with an ICD should have had the device interrogated within 6 months prior to the scheduled procedure.</span></li>
</ul>
<div class="table">
<p class="TABLEpNUM" id="ttC-4"><strong><span class="tab">Table&#160;C.4</span> Essential Elements of the Information Given to the CIED Physician</strong></p>
<table class="table">
<tr>
<td class="td3"><p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Type of procedure</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Anatomic location of surgical procedure</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Patient position during the procedure</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Will monopolar electrosurgery be used? (If so, anatomic location of EMI delivery.)</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Will other sources of EMI likely be present?</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Will cardioversion or defibrillation be used?</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Surgical venue (operating room, procedure suite, etc)</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Anticipated postprocedural arrangements (anticipated discharge to home &#x003C;23 h, inpatient admission to critical care bed, telemetry bed)</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Unusual circumstances: Cardiothoracic or chest wall surgical procedure that could impair/damage or encroach upon the CIED leads, anticipated large blood loss, operation in close proximity to CIED</p></td>
</tr>
</table>
<p class="tfoot">Reproduced with permission from Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors: Facilities and Patient Management. This document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). <em>Heart Rhythm</em>. 2011;8(7):1114-1154.</p>
</div>
<a id="page970"></a>
<div class="table">
<p class="TABLEpNUM" id="ttC-5"><strong><span class="tab">Table&#160;C.5</span> Essential Elements of the Preoperative CIED Evaluation to be Provided to the Operative Team</strong></p>
<table class="table">
<tr>
<td class="td3"><p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Date of last device interrogation</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Type of device: Pacemaker ICD, CRT-D, CRT-P, ILR, implantable hemodynamic monitor</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Manufacturer and model</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Indication for device</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Pacemaker: Sick sinus syndrome, AV block, syncope</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;ICD: Primary or secondary prevention</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Cardiac resynchronization therapy</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Battery longevity documented as &#x003E;3 mo</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Are any of the leads &#x003C;3 mo old?</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Programming</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Pacing mode and programmed lower rate</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;ICD therapy</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Lowest heart rate for shock delivery</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Lowest heart rate for ATP delivery</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Rate-responsive sensor type, if programmed on</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Is the patient pacemaker-dependent, and what is the underlying rhythm and heart rate if it can be determined?</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;What is the response of this device to magnet placement?</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Magnet pacing rate for a pacemaker</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Pacing amplitude response to magnet function</p>
<p class="TbBL2"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Will ICD detections resume automatically with removal of the magnet? Does this device allow for magnet application function to be disabled? If so, document programming of patient&#x2019;s device for this feature</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Any alert status on CIED generator or lead</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Last pacing threshold: Document adequate safety margin with the date of that threshold</p></td>
</tr>
</table>
<p class="tfoot">Reproduced with permission from Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors: Facilities and Patient Management. This document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). <em>Heart Rhythm</em>. 2011;8(7):1114-1154.</p>
</div>
<ul class="u_bullb">
<li><span>The inactivation of the ICD or programming of a pacemaker to asynchronous mode is recommended when electromagnetic interference (EMI) is likely to occur.</span></li>
<li><span>In patients in whom the ICD antiarrhythmia detection is turned off, an external defibrillator should be immediately available and ready to deliver therapy.</span></li>
<li><span>In cases where EMI is likely, the function of the CIED can be altered either by a ferrous magnet or by reprogramming. (see below for magnet response for ICD.)</span></li>
<li><span>Magnet response: Placing a magnet over a pacemaker generator will turn the pacemaker to asynchronous mode in most models. Placing a magnet over an ICD will suspend the arrhythmia detection. It will not switch the pacemaker function to asynchronous mode; therefore, in patients who are pacemaker-dependent, the team must be aware of the risk of inhibition of the pacemaker by EMI. If EMI is likely to occur, the recommendation is<a id="page971"></a> to reprogram the CIED prior to the operation by turning off the arrhythmia detection function and programming the pacemaker to asynchronous mode. Due to the fact that a minority of models do not respond to magnet application in the fashion described above, it is always recommended to contact the manufacturer and confirm the response to a magnet for the specific model one is dealing with (<strong><a href="#ttC-6">Table C.6</a></strong>; <strong><a href="#ffC-1">Figure C.1</a></strong>).</span></li></ul>
<div class="table">
<p class="TABLEpNUM" id="ttC-6"><strong><span class="tab">Table&#160;C.6</span> Example of a Stepwise Approach to the Perioperative Management of the Patient With a Cardiac Implantable Electronic Device</strong></p>
<table class="table">
<colgroup>
<col style="width:33%;"></col>
<col style="width:33%;"></col>
<col style="width:34%;"></col>
</colgroup>
<tr>
<td class="theadleft"><strong>Perioperative Period</strong></td>
<td class="theadleft"><strong>Patient/CIED Condition</strong></td>
<td class="theadleft"><strong>Intervention</strong></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Preoperative evaluation</strong></p></td>
<td class="td2"><p class="tbodyleft">Patient has CIED</p></td>
<td class="td2"><p class="tbodyleft">Focused history</p>
<p class="tbodyleft">Focused physical examination</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">Determine CIED type (PM, ICD, CRT)</p></td>
<td class="td2"><p class="tbodyleft">Manufacturer&#x2019;s CIED identification card</p>
<p class="tbodyleft">Chest x-ray (no data available) Supplemental resources<sup>a</sup></p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">Determine if patient is CIED-dependent for pacing function</p></td>
<td class="td2"><p class="tbodyleft">Verbal history</p>
<p class="tbodyleft">Bradyarrhythmia symptoms</p>
<p class="tbodyleft">Atrioventricular node ablation</p>
<p class="tbodyleft">No spontaneous ventricular activity<sup>b</sup></p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">Determine CIED function</p></td>
<td class="td2"><p class="tbodyleft">Comprehensive CIED evaluation<sup>c</sup></p>
<p class="tbodyleft">Determine if pacing pulses are present and create paced beats</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Preoperative preparation</strong></p></td>
<td class="td3"><p class="tbodyleft">EMI unlikely during procedure</p></td>
<td class="td3"><p class="tbodyleft">If EMI is unlikely, then special precautions are not needed</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td3"><p class="tbodyleft">EMI likely; CIED is PM</p></td>
<td class="td3"><p class="tbodyleft">Reprogram to asynchronous mode when indicated</p>
<p class="tbodyleft">Suspend rate-adaptive functions<sup>d</sup></p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td3"><p class="tbodyleft">EMI likely; CIED is ICD</p></td>
<td class="td3"><p class="tbodyleft">Suspend antitachyarrhythmia functions. If patient is dependent on pacing function, then alter pacing function as above</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td3"><p class="tbodyleft">EMI likely; All CIED</p></td>
<td class="td3"><p class="tbodyleft">Use bipolar cautery; ultrasonic scalpel</p>
<p class="tbodyleft">Temporary pacing and cardioversion-defibrillation available</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td3"><p class="tbodyleft">Intraoperative physiologic changes likely (eg, bradycardia, ischemia)</p></td>
<td class="td3"><p class="tbodyleft">Plan for possible adverse CIED-patient interaction</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Intraoperative management</strong></p></td>
<td class="td2"><p class="tbodyleft">Monitoring</p></td>
<td class="td2"><p class="tbodyleft">Electrocardiographic monitoring per ASA standard</p>
<p class="tbodyleft">Peripheral pulse monitoring</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">Electrocautery interference</p></td>
<td class="td2"><p class="tbodyleft">CT/CRP no current through PG/leads</p>
<p class="tbodyleft">Avoid proximity of CT to PG/leads</p>
<p class="tbodyleft">Short bursts at lowest possible energy</p>
<p class="tbodyleft">Use bipolar cautery; ultrasonic scalpel</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">RF catheter ablation</p></td>
<td class="td2"><p class="tbodyleft">Avoid contact of RF catheter with PG/leads</p>
<p class="tbodyleft">RF current path far away from PG/leads</p>
<p class="tbodyleft">Discuss these concerns with operator</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">Lithotripsy</p></td>
<td class="td2"><p class="tbodyleft">Do not focus lithotripsy beam near PG</p>
<p class="tbodyleft">R wave triggers lithotripsy? Disable atrial pacing</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><a id="page972"></a>&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">MRI</p></td>
<td class="td2"><p class="tbodyleft">Generally contraindicated</p>
<p class="tbodyleft">If required, consult ordering physician, cardiologist, radiologist, and manufacturer</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">Radiation therapy</p></td>
<td class="td2"><p class="tbodyleft">PG/leads must be outside of RT field</p>
<p class="tbodyleft">Possible surgical relocation of PG</p>
<p class="tbodyleft">Verify PG function during/after RT course</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">ECT</p></td>
<td class="td2"><p class="tbodyleft">Consult with ordering physician, patient&#x2019;s cardiologist, a CIED service, or CIED manufacturer</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Emergency defibrillation-cardioversion</strong></p></td>
<td class="td2"><p class="tbodyleft">ICD: magnet-disabled</p></td>
<td class="td2"><p class="tbodyleft">Terminate all EMI sources</p>
<p class="tbodyleft">Remove magnet to reenable therapies</p>
<p class="tbodyleft">Observe for appropriate therapies</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">ICD: programming disabled</p></td>
<td class="td2"><p class="tbodyleft">Programming to reenable therapies or proceed directly with external cardioversion/defibrillation</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">ICD: either of above</p></td>
<td class="td2"><p class="tbodyleft">Minimize current flow through PG/leads</p>
<p class="tbodyleft">PP as far as possible from PG</p>
<p class="tbodyleft">PP perpendicular to major axis PG/leads</p>
<p class="tbodyleft">To extent possible, PP in anterior&#x2013;posterior location</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td2"><p class="tbodyleft">Regardless of CIED type</p></td>
<td class="td2"><p class="tbodyleft">Use clinically appropriate cardioversion/defibrillation energy</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Postoperative management</strong></p></td>
<td class="td3"><p class="tbodyleft">Immediate postoperative period</p></td>
<td class="td3"><p class="tbodyleft">Monitor cardiac R&#x0026;R continuously</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft">&#x00A0;</p></td>
<td class="td3"><p class="tbodyleft">Postoperative interrogation and restoration of CIED function</p></td>
<td class="td3"><p class="tbodyleft">Back-up pacing and cardioversion/defibrillation capability</p>
<p class="tbodyleft">Interrogation to assess function</p>
<p class="tbodyleft">Settings appropriate?<sup>e</sup></p>
<p class="tbodyleft">Is CIED an ICD?<sup>f</sup></p>
<p class="tbodyleft">Use cardiology/PM-ICD service if needed</p></td>
</tr>
</table>
<p class="tfoot"><sup>a</sup>Manufacturer&#x2019;s databases, pacemaker clinic records, cardiology consultation.</p>
<p class="u_tfoot"><sup>b</sup>With cardiac rhythm management device (CRMD) programmed VVI at lowest programmable rate.</p>
<p class="u_tfoot"><sup>c</sup>Ideally, CIED function assessed by interrogation, with function altered by reprogramming if required.</p>
<p class="u_tfoot"><sup>d</sup>Most times, this will be necessary; when in doubt, assume so.</p>
<p class="u_tfoot"><sup>e</sup>If necessary, reprogram appropriate setting.</p>
<p class="u_tfoot"><sup>f</sup>Restore all antitachycardia therapies.</p>
<p class="u_tfoot">Reproduced with permission from: Practice advisory for perioperative management of patients with cardiac rhythm management devices: Pacemakers and implantable cardioverter-defibrillators. A report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. <em>Anesthesiology</em>. 2011;114:247-261. Table 3.</p>
</div>
<a id="page973"></a>
<div class="figure" id="ffC-1"><figure class="figure"><img src="images/ffc-1.jpg" alt="img"/><figcaption class="caption"><span class="fignum">Figure&#160;C.1</span> Example of an algorithm for perioperative management of patients with CIED. (From Stone ME, Salter B, Fischer A. Perioperative management of patients with cardiac implantable electronic devices. <em>Br J Anaesth</em>. 2011;107(suppl 1):i16-i26. Figure 3, with permission.)</figcaption></figure></div>
<p class="h7a">Risk Mitigation Strategies</p>
<ul class="u_bullb"><li><span>Have a magnet available.</span></li>
<li><span>Use bipolar cautery where possible.</span></li>
<li><span>Use short bursts of monopolar cautery (5 seconds or less).</span></li>
<li><span>Place the return current pad in such a way to avoid current crossing the generator.</span></li>
<li><span>Have rescue equipment, including external pacemaker/defibrillator, immediately available for all patients with a CIED.</span></li>
<li><span>Be aware of other potential sources of EMI in addition to electrocautery.</span></li>
<li><span>Be aware of dislodgement of leads during atrial fibrillation ablations, central intravenous catheter insertions, or other catheter-based procedures.</span></li></ul>
<a id="page974"></a>
<p class="h7a">Recommendations for Postoperative Follow-up of the Patient With CIED (see <a href="#ttC-7">Tables C.7</a> and <a href="#ttC-8">C.8</a>)</p>
<ul class="u_bullb"><li><span>Note the <em>Practice Advisory for the Perioperative Management of Patients with Cardiac Implantable Electronic Devices: Pacemakers and Implantable Cardioverter-Defibrillators</em> states that &#x201C;postoperative patient management should include interrogating and restoring CIED function in the postanesthesia care unit or intensive care unit.&#x201D;</span></li></ul>
<div class="table">
<p class="TABLEpNUM" id="ttC-7"><strong><span class="tab">Table&#160;C.7</span> Specific Procedures and Writing Committee Recommendations on Postoperative CIED Evaluation</strong></p>
<table class="table">
<colgroup>
<col style="width:50%;"></col>
<col style="width:50%;"></col>
</colgroup>
<tr>
<td class="theadleft"><strong>Procedure</strong></td>
<td class="theadleft"><strong>Recommendation</strong></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Monopolar electrosurgery</strong></p></td>
<td class="td2"><p class="tbodyleft">CIED evaluated<sup>a</sup> within 1 mo from procedure unless Table C.8 criteria are fulfilled</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>External cardioversion</strong></p></td>
<td class="td3"><p class="tbodyleft">CIED evaluated<sup>a</sup> prior to discharge or transfer from cardiac telemetry</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Radiofrequency ablation</strong></p></td>
<td class="td2"><p class="tbodyleft">CIED evaluated<sup>a</sup> prior to discharge or transfer from cardiac telemetry</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Electroconvulsive therapy</strong></p></td>
<td class="td3"><p class="tbodyleft">CIED evaluated<sup>a</sup> within 1 mo from procedure unless fulfilling Table C.8 criteria</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Nerve conduction studies (electroneurography [ENG])</strong></p></td>
<td class="td2"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Ocular procedures</strong></p></td>
<td class="td3"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Therapeutic radiation</strong></p></td>
<td class="td2"><p class="tbodyleft">CIED evaluated prior to discharge or transfer from cardiac telemetry; remote monitoring optimal; some instances may indicate interrogation after each treatment (see text)</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>TUNA/TURP</strong></p></td>
<td class="td3"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Hysteroscopic ablation</strong></p></td>
<td class="td2"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Lithotripsy</strong></p></td>
<td class="td3"><p class="tbodyleft">CIED evaluated<sup>a</sup> within 1 mo from procedure unless fulfilling Table C.8 criteria</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Endoscopy</strong></p></td>
<td class="td2"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Iontophoresis</strong></p></td>
<td class="td3"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Photodynamic therapy</strong></p></td>
<td class="td2"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>X-ray/CT scans/mammography</strong></p></td>
<td class="td3"><p class="tbodyleft">No additional CIED evaluation beyond routine</p></td>
</tr>
</table>
<p class="tfoot">CIED, cardiac implantable electronic device; CT, computed tomography; TUNA, transurethral needle ablation; TURP, transurethral resection of prostate.</p>
<p class="u_tfoot"><sup>a</sup>This evaluation is intended to reveal electrical reset. Therefore, an interrogation alone is needed. This can be accomplished in person or by remote telemetry.</p>
<p class="u_tfoot">Reproduced with permission from: Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors: Facilities and Patient Management. This document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). <em>Heart Rhythm</em>. 2011;8(7):1114-1154.</p>
</div>
<a id="page975"></a>
<div class="table">
<p class="TABLEpNUM" id="ttC-8"><strong><span class="tab">Table&#160;C.8</span> Indications for the Interrogation of CIEDS Prior to Patient Discharge or Transfer from a Cardiac Telemetry Environment</strong></p>
<table class="table">
<tr>
<td class="td3"><p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Patients with CIEDs reprogrammed prior to the procedure that left the device nonfunctional such as disabling tachycardia detection in an ICD.</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Patients with CIEDs who underwent hemodynamically challenging surgeries such as cardiac surgery or significant vascular surgery (eg, abdominal aortic aneurysmal repair).<sup>a</sup></p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Patients with CIEDs who experienced significant intraoperative events including cardiac arrest requiring temporary pacing or cardiopulmonary resuscitation and those who required external electrical cardioversion.</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Emergent surgery where the site of EMI exposure was above the umbilicus.</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Cardiothoracic surgery.</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Patients with CIEDs who underwent certain types of procedures (Table C.7) that emit EMI with a greater probability of affecting device function.</p>
<p class="U_TbBL1"><span class="u_blue">&#x2022;</span>&#x00A0;&#x00A0;Patients with CIEDs who have logistical limitations that would prevent reliable device evaluation within 1 mo from their procedure.</p></td>
</tr>
</table>
<p class="tfoot">CIED, cardiac implantable electrical device; EMI, electromagnetic interference; ICD, implantable cardiac defibrillator.</p>
<p class="u_tfoot"><sup>a</sup>The general purpose of this interrogation is to ensure that reset did not occur. In these cases, a full evaluation including threshold evaluations is suggested.</p>
<p class="u_tfoot">Reproduced with permission from Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors: Facilities and Patient Management. This document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). <em>Heart Rhythm</em>. 2011;8(7):1114-1154.</p>
</div>
<p class="h7a">Optimization of Pacing After Cardiopulmonary Bypass (CPB)</p>
<p class="nonindent">During separation from CPB, it is not uncommon for a patient to develop a conduction abnormality, ranging from the more benign first-degree AV block or sinus bradycardia to the more severe interventricular delays or third-degree AV block.</p>
<p class="indent"><strong>Optimizing pacing:</strong></p>
<ol class="u_num2">
<li><span><strong>Lead placement:</strong> Right atrial (RA) lead&#x2014;place at the cephalic atrial wall, between the atrial appendages. Right ventricular lead&#x2014;place at the level of the right ventricle outflow tract (RVOT). For the patient with obstructive cardiomyopathy, the RV lead is better placed in the RV apex for less dynamic obstruction of the LVOT. Biventricular pacing can be initiated for patients with intraventricular conduction lesions and dyssynchrony of contraction. The LV lead should be placed at the basal posterolateral wall, and the two ventricular leads can be connected through a Y piece to the ventricular output of the temporary pacemaker box.</span></li>
<li><span><strong>Rate:</strong> Program to obtain the best improvement in cardiac output and improvement in mixed venous saturation and arterial blood pressure.</span></li>
<li><span><strong>AV delay:</strong> In patients with LV dysfunction, we can maximize the contribution of the atria to the preload. Use pulse wave Doppler through the mitral valve inflow and modify the AV delay to obtain clear E and A waveforms and to ensure that the A wave ends before the onset of the<a id="page976"></a> QRS. The closure of the mitral valve should happen at the end of the A wave but before any diastolic mitral regurgitation. If echocardiography is not available, adjust the AV interval to achieve highest cardiac output. (<strong><a href="#ttC-9">Table C.9</a></strong>)</span></li>
<li><span><strong>Pacing mode:</strong> Three modes are explained here. In the patient with normal AV conduction, AAI mode allows for an increase in HR and a physiologic depolarization of the ventricles. If inhibition by electrocautery is a concern, use asynchronous pacing in AOO mode. For the patient with AV conduction delay, DOO or DDI should be used. DDI mode also avoids tracking of rapid atrial rates in cases of postbypass atrial fibrillation.</span></li>
<li><span><strong>Biventricular pacing:</strong> In patients with EF &#x2264;35% and QRS &#x2265;120 ms, acute biventricular pacing improves torsion and mechanics of contraction, particularly in patients with mitral regurgitation due to papillary muscle dyssynchrony. Speckle-tracking, 3D echocardiography, M-mode definition of septal to wall motion delay, color Doppler tissue imaging, and analysis of segmental velocity are used to characterize ventricular dyssynchrony. Currently available temporary pacemakers only allow biventricular pacing through a Y connection of the two ventricular epicardial wires to the ventricular output of the box. Acute CRT leads to an increase in myocardial performance with a slight decrease in myocardial oxygen consumption.</span></li></ol>
<div class="table">
<p class="TABLEpNUM" id="ttC-9"><strong><span class="tab">Table&#160;C.9</span> Treatment of Pacemaker Failure</strong></p>
<table class="table">
<colgroup>
<col style="width:50%;"></col>
<col style="width:50%;"></col>
</colgroup>
<tr>
<td class="theadleft"><strong>Rate</strong></td>
<td class="theadleft"><strong>Possible Response</strong></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Adequate to maintain blood pressure</strong></p></td>
<td class="td2"><p class="TbNL1">1. Oxygen, airway control</p>
<p class="TbNL1">2. Place magnet over pacemaker</p>
<p class="TbNL1">3. Atropine if sinus bradycardia</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Severe bradycardia and hypotension</strong></p></td>
<td class="td3"><p class="TbNL1">1. Oxygen, airway control</p>
<p class="TbNL1">2. Place magnet over pacemaker</p>
<p class="TbNL1">3. Other types of pacing if magnet does not activate the pacemaker (transcutaneous, esophageal, or transvenous)</p>
<p class="TbNL1">4. Atropine if sinus bradycardia</p>
<p class="TbNL1">5. Isoproterenol to increase ventricular rate</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>No escape rhythm</strong></p></td>
<td class="td2"><p class="TbNL1">1. Cardiopulmonary resuscitation</p>
<p class="TbNL1">2. Place magnet over pacemaker</p>
<p class="TbNL1">3. Other types of pacing if magnet does not activate the pacemaker (transcutaneous, esophageal, or transvenous)</p>
<p class="TbNL1">4. Isoproterenol to increase ventricular rate</p></td>
</tr>
</table>
<p class="tfoot">Dervied from Zaidan JR, Youngberg JA, Lake CL, et al, eds. <em>Pacemakers, Cardiac, Vascular and Thoracic Anesthesia</em>. Churchill Livingstone; 2000.</p>
</div>
<p class="h7a">Acknowledgments</p>
<p class="nonindent">The editors of the 2nd edition gratefully acknowledge the past contributions of Gina C. Badescu, Benjamin M. Sherman, James R. Zaidan, and Paul G. Barash.</p>
</div>
</section>
</body>
</html>